FDA Inspection 958740 — New York Blood Center Enterprises
The FDA completed an inspection of New York Blood Center Enterprises on Feb 16, 2016 in Rockville Centre, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 16, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Rockville Centre, NY (United States)